Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet BK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   2.0% 1.7% 1.6% 1.4% 1.6% 2.1% 9.9% 9.9%   Credit score (0-100)   70 75 74 78 74 66 25 25   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   0.3 3.3 5.4 38.0 6.2 0.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,356 3,089 3,401 3,982 3,247 4,603 0.0 0.0   EBITDA   367 561 531 721 332 2,538 0.0 0.0   EBIT   367 561 531 646 257 2,480 0.0 0.0   Pre-tax profit (PTP)   218.9 447.5 424.0 637.0 248.8 2,523.7 0.0 0.0   Net earnings   155.4 335.5 313.2 482.0 181.0 2,141.7 0.0 0.0   Pre-tax profit without non-rec. items   349 554 527 637 249 2,524 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,357 2,250 2,121 2,047 1,972 1,887 0.0 0.0   Shareholders equity total   1,675 1,860 2,023 2,355 2,286 4,328 2,128 2,128   Interest-bearing liabilities   433 433 418 216 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,016 2,862 3,268 3,249 2,712 4,815 2,128 2,128   Net Debt   157 97.3 -565 -652 -528 -279 -2,128 -2,128     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,356 3,089 3,401 3,982 3,247 4,603 0.0 0.0   Gross profit growth   1.9% -7.9% 10.1% 17.1% -18.5% 41.8% -100.0% 0.0%   Employees   6 6 6 6 6 6 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,016 2,862 3,268 3,249 2,712 4,815 2,128 2,128   Balance sheet change%   5.5% -5.1% 14.2% -0.6% -16.5% 77.6% -55.8% 0.0%   Added value   367.4 561.0 530.7 721.0 332.1 2,538.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -130 -106 -129 -149 -150 -143 -1,887 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.9% 18.2% 15.6% 16.2% 7.9% 53.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.5% 19.1% 17.3% 19.8% 8.6% 67.1% 0.0% 0.0%   ROI %   18.3% 26.1% 22.7% 25.8% 10.6% 75.6% 0.0% 0.0%   ROE %   9.7% 19.0% 16.1% 22.0% 7.8% 64.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   55.7% 65.1% 62.0% 72.6% 84.4% 89.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   42.7% 17.3% -106.5% -90.4% -159.2% -11.0% 0.0% 0.0%   Gearing %   25.9% 23.3% 20.7% 9.2% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.1% 1.7% 0.8% 2.8% 7.7% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.8 1.2 1.8 1.8 6.9 0.0 0.0   Current Ratio   0.6 0.8 1.2 1.8 1.7 6.9 0.0 0.0   Cash and cash equivalent   276.3 335.6 983.7 868.0 528.2 278.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -357.0 -120.0 166.7 524.0 314.5 2,503.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   61 93 88 120 55 423 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   61 93 88 120 55 423 0 0   EBIT / employee   61 93 88 108 43 413 0 0   Net earnings / employee   26 56 52 80 30 357 0 0